About Us

Home » About Us » CEO Dr Jason Rutt

Dr Jason Rutt

A photograph of Jason Rutt

CEO Dr Jason Rutt
Ex Pfizer UK
Patent head

Jason has a degree and PhD in Chemistry from Imperial College and Nottingham University. After leaving research he qualified as a UK and European Patent Attorney, going on to become Head of Pfizer’s UK Patent Dept and member of Site Management team. Before founding Azadyne, Jason worked with a number of UK biotech start-ups. 

Azadyne is a pre-clinical stage company exploiting a novel drug target and pathway that provides a paradigm shift in the treatment of autoimmune diseases